125 related articles for article (PubMed ID: 3620716)
1. Influence of height, weight, and obesity on breast cancer incidence and recurrence in Auckland, New Zealand.
McNee RK; Mason BH; Neave LM; Kay RG
Breast Cancer Res Treat; 1987; 9(2):145-50. PubMed ID: 3620716
[TBL] [Abstract][Full Text] [Related]
2. Incidence and clinical features of breast cancer in the Auckland region.
Newman PD; Mason BH; Holdaway IM; Kay RG; Arthur JF; Hitchcock GC
N Z Med J; 1992 Apr; 105(931):117-20. PubMed ID: 1313956
[TBL] [Abstract][Full Text] [Related]
3. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women.
Biglia N; Peano E; Sgandurra P; Moggio G; Pecchio S; Maggiorotto F; Sismondi P
Gynecol Endocrinol; 2013 Mar; 29(3):263-7. PubMed ID: 23174088
[TBL] [Abstract][Full Text] [Related]
4. Pre-morbid body-mass-index in breast cancer: reversed effect on survival in hormone receptor negative patients.
Maehle BO; Tretli S
Breast Cancer Res Treat; 1996; 41(2):123-30. PubMed ID: 8944330
[TBL] [Abstract][Full Text] [Related]
5. Body mass index (BMI): association with clinicopathological factors and outcome of women with newly diagnosed breast cancer in New Zealand.
Robinson B; Currie M; Phillips E; Dachs G; Strother M; Morrin H; Davey V; Frampton C
N Z Med J; 2017 Mar; 130(1451):46-56. PubMed ID: 28253244
[TBL] [Abstract][Full Text] [Related]
6. Recurrence dynamics of breast cancer according to baseline body mass index.
Biganzoli E; Desmedt C; Fornili M; de Azambuja E; Cornez N; Ries F; Closon-Dejardin MT; Kerger J; Focan C; Di Leo A; Nogaret JM; Sotiriou C; Piccart M; Demicheli R
Eur J Cancer; 2017 Dec; 87():10-20. PubMed ID: 29096156
[TBL] [Abstract][Full Text] [Related]
7. Obesity and breast cancer outcomes in chemotherapy patients in New Zealand - a population-based cohort study.
Elwood JM; Tin Tin S; Kuper-Hommel M; Lawrenson R; Campbell I
BMC Cancer; 2018 Jan; 18(1):76. PubMed ID: 29334917
[TBL] [Abstract][Full Text] [Related]
8. Season of tumour detection influences factors predicting survival of patients with breast cancer.
Mason BH; Holdaway IM; Stewart AW; Neave LM; Kay RG
Breast Cancer Res Treat; 1990 Jan; 15(1):27-37. PubMed ID: 2328328
[TBL] [Abstract][Full Text] [Related]
9. The associations of obesity, lymph node status and prognosis in breast cancer patients: dependence on estrogen and progesterone receptor status.
Maehle BO; Tretli S; Thorsen T
APMIS; 2004 Jun; 112(6):349-57. PubMed ID: 15511272
[TBL] [Abstract][Full Text] [Related]
10. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women.
Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K
J BUON; 2013; 18(2):335-41. PubMed ID: 23818343
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
[TBL] [Abstract][Full Text] [Related]
12. Obesity increases the incidence of distant metastases in oestrogen receptor-negative human epidermal growth factor receptor 2-positive breast cancer patients.
Mazzarella L; Disalvatore D; Bagnardi V; Rotmensz N; Galbiati D; Caputo S; Curigliano G; Pelicci PG
Eur J Cancer; 2013 Nov; 49(17):3588-97. PubMed ID: 23953055
[TBL] [Abstract][Full Text] [Related]
13. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
14. Body weight and prognostic indicators in breast cancer. Modifying effect of estrogen receptors.
Verreault R; Brisson J; Deschênes L; Naud F
Am J Epidemiol; 1989 Feb; 129(2):260-8. PubMed ID: 2912039
[TBL] [Abstract][Full Text] [Related]
15. Body mass index influences palpability but not stage of breast cancer at diagnosis.
Chagpar AB; McMasters KM; Saul J; Nurko J; Martin RC; Scoggins CR; Edwards MJ
Am Surg; 2007 Jun; 73(6):555-60; discussion 560. PubMed ID: 17658091
[TBL] [Abstract][Full Text] [Related]
16. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer.
Cespedes Feliciano EM; Kwan ML; Kushi LH; Chen WY; Weltzien EK; Castillo AL; Sweeney C; Bernard PS; Caan BJ
Cancer; 2017 Jul; 123(13):2535-2542. PubMed ID: 28295245
[TBL] [Abstract][Full Text] [Related]
17. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study.
Suzuki R; Iwasaki M; Inoue M; Sasazuki S; Sawada N; Yamaji T; Shimazu T; Tsugane S;
Int J Cancer; 2011 Sep; 129(5):1214-24. PubMed ID: 21064092
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer subtype approximations and loco-regional recurrence after immediate breast reconstruction.
Kneubil MC; Brollo J; Botteri E; Curigliano G; Rotmensz N; Goldhirsch A; Lohsiriwat V; Manconi A; Martella S; Santillo B; Petit JY; Rietjens M
Eur J Surg Oncol; 2013 Mar; 39(3):260-5. PubMed ID: 23313014
[TBL] [Abstract][Full Text] [Related]
19. Distinct Effects of Body Mass Index and Waist/Hip Ratio on Risk of Breast Cancer by Joint Estrogen and Progestogen Receptor Status: Results from a Case-Control Study in Northern and Eastern China and Implications for Chemoprevention.
Wang F; Liu L; Cui S; Tian F; Fan Z; Geng C; Cao X; Yang Z; Wang X; Liang H; Wang S; Jiang H; Duan X; Wang H; Li G; Wang Q; Zhang J; Jin F; Tang J; Li L; Zhu S; Zuo W; Ma Z; Zhou F; Yu L; Xiang Y; Li L; Shen S; Yu Z
Oncologist; 2017 Dec; 22(12):1431-1443. PubMed ID: 28912152
[TBL] [Abstract][Full Text] [Related]
20. Obesity at diagnosis of breast carcinoma influences duration of disease-free survival.
Senie RT; Rosen PP; Rhodes P; Lesser ML; Kinne DW
Ann Intern Med; 1992 Jan; 116(1):26-32. PubMed ID: 1727092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
